Faruque Ghanchi
20PUBLICATIONS
61CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (20)
Sort by Publication Date:
|Jan 16, 2026
Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel.Richard Gale, Mahmoud Husseiny Awad, Clare Bailey
|May 12, 2025
Visual outcome following initiation of first injection versus after three monthly doses of aflibercept 2 mg for treatment naïve age-related macular degeneration to inform clinical trial designs: PRECISE Report No. 6.Swati Chandak, Sarega Gurudas, Raheeba Pakeer Muhammed
|Feb 21, 2025
Factors associated with achieving various visual acuity outcomes during loading doses of aflibercept 2 mg for treatment naïve exudative age-related macular degeneration: PRECISE Study Report 7.Swati Chandak, Sarega Gurudas, Raheeba Mohammed Pakeer
|May 28, 2024
The UK clinical eye research strategy: refreshing research priorities for clinical eye research in the UK.Rupert R A Bourne, Malik Moledina, Augusto Azuara-Blanco
|May 06, 2024
Impact of treat and extend criteria on proportions that can be extended after loading phase of 2 mg aflibercept therapy for neovascular age related macular degeneration: PRECISE Report 5.Sridevi Thottarath, Sarega Gurudas, Swati Chandak
|Dec 15, 2023
Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3.Shruti Chandra, Sarega Gurudas, Ian Pearce
Pageof 4
Frequent Collaborators
5 joint publications
Sobha Sivaprasad
5 joint publications
Anna Grabowska
5 joint publications
Benjamin Jl Burton
5 joint publications
Martin Mckibbin
4 joint publications
Praveen Patel
4 joint publications
Victor Chong
4 joint publications
Peter Scanlon
4 joint publications
Swati Chandak
3 joint publications
James Talks
3 joint publications
Andrew Nolan
